TrialJournal for immunotherapy of cancer2022

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.

Carey K Anders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.